Dunlop has received research support from Boehringer Ingelheim, Compass Pathways, NIMH, Otsuka, Sage, Usona Institute, and Takeda and has served as a consultant for Biohaven, Cerebral Therapeutics, Myriad Neuroscience, NRx Pharmaceuticals, Otsuka, and Sage
Treatment Duration: The Long Game Microdosing is rarely a quick fix
In its Phase I/II Brainshuttle AD study, 92% of people receiving trontinemab showed no measurable amyloid plaques after 28 weeks of treatment
But the pharmacy board has reported numerous abuses by Ohio spas and weight-loss clinics over the past year
Together, we can achieve your goals, and remember, support is always available to help navigate this important journey
The result is that patients feel more satiated after a meal, so they consume fewer calories